507 784

Cited 11 times in

Resistance Trends of Bacteroides fragilis Group Over an 8-Year Period, 1997-2004, in Korea

DC Field Value Language
dc.contributor.author이경원-
dc.contributor.author정윤섭-
dc.contributor.author김신영-
dc.contributor.author김준명-
dc.contributor.author김창기-
dc.contributor.author염종화-
dc.contributor.author용동은-
dc.date.accessioned2015-04-24T16:55:25Z-
dc.date.available2015-04-24T16:55:25Z-
dc.date.issued2009-
dc.identifier.issn1598-6535-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/104426-
dc.description.abstractBACKGROUND: Bacteroides fragilis group organisms are the most frequently isolated anaerobes in human infections. Increasing resistance to various antimicrobial agents is a significant problem in choosing appropriate antimicrobial agents to treat anaerobic infections. Periodic monitoring of the regional resistance trends of B. fragilis group isolates is needed. METHODS: A total of 466 nonduplicate clinical isolates of B. fragilis group organisms (276 B. fragilis, 106 Bacteroides thetaiotaomicron, and 84 other B. fragilis group organisms) were collected during the 8-yr period from 1997 to 2004 in a Korean university hospital. Minimum inhibitory concentrations to various antimicrobial agents were determined by the CLSI agar dilution method. RESULTS: Eight isolates were resistant to imipenem. Additionally, the resistance rates to cefotetan were decreased in B. thetaiotaomicron, while those for clindamycin were significantly increased compared to the rates found in previous studies. Depending on species, resistance rates were 1-4% for imipenem, 1-6% for piperacillin-tazobactam, 4-11% for cefoxitin, 33-49% for piperacillin, 14-60% for cefotetan, and 51-76% for clindamycin. No isolates were resistant to chloramphenicol or metronidazole. CONCLUSIONS: Piperacillin-tazobactam, cefoxitin, imipenem, chloramphenicol, and metronidazole are still active against B. fragilis group isolates, while clindamycin no longer has a value as an empirical therapeutic agent in Korea. Furthermore, this study identified the first imipenem-resistant B. fragilis group isolates in Korea-
dc.description.statementOfResponsibilityopen-
dc.format.extent293~298-
dc.relation.isPartOfKOREAN JOURNAL OF LABORATORY MEDICINE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnti-Bacterial Agents/pharmacology-
dc.subject.MESHBacteroides/classification-
dc.subject.MESHBacteroides/drug effects*-
dc.subject.MESHBacteroides/isolation & purification-
dc.subject.MESHBacteroides fragilis/drug effects-
dc.subject.MESHBacteroides fragilis/isolation & purification-
dc.subject.MESHCefoxitin/pharmacology-
dc.subject.MESHChloramphenicol/pharmacology-
dc.subject.MESHDrug Resistance, Multiple, Bacterial*-
dc.subject.MESHHumans-
dc.subject.MESHImipenem/pharmacology-
dc.subject.MESHMetronidazole/pharmacology-
dc.subject.MESHMicrobial Sensitivity Tests-
dc.subject.MESHPenicillanic Acid/analogs & derivatives-
dc.subject.MESHPenicillanic Acid/pharmacology-
dc.subject.MESHPiperacillin/pharmacology-
dc.subject.MESHRepublic of Korea-
dc.titleResistance Trends of Bacteroides fragilis Group Over an 8-Year Period, 1997-2004, in Korea-
dc.title.alternative국내 분리 Bacteroides fragilis군의 8년간 내성률 변화(1997-2004)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorKyoung Ho Roh-
dc.contributor.googleauthorSinyoung Kim-
dc.contributor.googleauthorChang-Ki Kim-
dc.contributor.googleauthorJong Hwa Yum-
dc.contributor.googleauthorMyung Sook Kim-
dc.contributor.googleauthorDongeun Yong-
dc.contributor.googleauthorKyungwon Lee-
dc.contributor.googleauthorJune Myung Kim-
dc.contributor.googleauthorYunsop Chong-
dc.identifier.doi10.3343/kjlm.2009.29.4.293-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02649-
dc.contributor.localIdA03679-
dc.contributor.localIdA00675-
dc.contributor.localIdA00953-
dc.contributor.localIdA01038-
dc.contributor.localIdA02352-
dc.contributor.localIdA02423-
dc.relation.journalcodeJ02044-
dc.identifier.pmid19726890-
dc.subject.keywordBacteroides fragilis group-
dc.subject.keywordAntimicrobial susceptibility-
dc.subject.keywordTrend-
dc.subject.keywordKorea-
dc.contributor.alternativeNameLee, Kyung Won-
dc.contributor.alternativeNameChong, Yun Sop-
dc.contributor.alternativeNameKim, Sin Young-
dc.contributor.alternativeNameKim, June Myung-
dc.contributor.alternativeNameKim, Chang Ki-
dc.contributor.alternativeNameYum, Jong Hwa-
dc.contributor.alternativeNameYong, Dong Eun-
dc.contributor.affiliatedAuthorLee, Kyung Won-
dc.contributor.affiliatedAuthorChong, Yun Sop-
dc.contributor.affiliatedAuthorKim, Sin Young-
dc.contributor.affiliatedAuthorKim, June Myung-
dc.contributor.affiliatedAuthorKim, Chang Ki-
dc.contributor.affiliatedAuthorYum, Jong Hwa-
dc.contributor.affiliatedAuthorYong, Dong Eun-
dc.citation.volume29-
dc.citation.number4-
dc.citation.startPage293-
dc.citation.endPage298-
dc.identifier.bibliographicCitationKOREAN JOURNAL OF LABORATORY MEDICINE , Vol.29(4) : 293-298, 2009-
dc.identifier.rimsid54107-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Laboratory Medicine (진단검사의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.